0
USD
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Pulmonary Arterial Hypertension Treatment Market Size, Status and Forecast 2021-2027
Published Date: January 2021
|
Report Code: QYRE-Auto-22N3918
Home | Category |Health |Health Conditions |Heart & Hypertension
Global Pulmonary Arterial Hypertension Treatment Market Size Status and Forecast 2021 2027

Global Pulmonary Arterial Hypertension Treatment Market Size, Status and Forecast 2021-2027

Code: QYRE-Auto-22N3918
Report
January 2021
94 Pages
QYResearch
Region: Global, North America, Europe, United States, Canada, Germany, UAE, Saudi Arabia, Turkey, Southeast Asia, France, Russia, Italy, South Korea,
Description
Table of Content
Tables & Figures
Pulmonary Arterial Hypertension Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Pulmonary Arterial Hypertension Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
    Vasodilators
    Phosphodiesterase 5 (PDE 5) Inhibitors
    Endothelin Receptor Antagonists (ERA)
    Soluble Guanylate Cyclase (SGC) Stimulator
Segment by Application
    Hospital Pharmacies
    Retail Pharmacies
    Online Pharmacies
By Region
    North America
        United States
        Canada
    Europe
        Germany
        France
        U.K.
        Italy
        Russia
        Nordic
        Rest of Europe
    Asia-Pacific
        China
        Japan
        South Korea
        Southeast Asia
        India
        Australia
        Rest of Asia
    Latin America
        Mexico
        Brazil
        Rest of Latin America
    Middle East & Africa
        Turkey
        Saudi Arabia
        UAE
        Rest of MEA
By Company
    GSK
    Eli Lilly and Company
    Pfizer Inc
    Actelion Inc
    United Therapeutic Corporation
    SteadyMed Ltd
    Gilead Sciences, Inc
    Teva Pharmaceuticals Inc
    Bayer AG
    Actelion Inc
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Pulmonary Arterial Hypertension Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Vasodilators
1.2.3 Phosphodiesterase 5 (PDE 5) Inhibitors
1.2.4 Endothelin Receptor Antagonists (ERA)
1.2.5 Soluble Guanylate Cyclase (SGC) Stimulator
1.3 Market by Application
1.3.1 Global Pulmonary Arterial Hypertension Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Pulmonary Arterial Hypertension Treatment Market Perspective (2016-2027)
2.2 Pulmonary Arterial Hypertension Treatment Growth Trends by Regions
2.2.1 Pulmonary Arterial Hypertension Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Pulmonary Arterial Hypertension Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Pulmonary Arterial Hypertension Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Pulmonary Arterial Hypertension Treatment Industry Dynamic
2.3.1 Pulmonary Arterial Hypertension Treatment Market Trends
2.3.2 Pulmonary Arterial Hypertension Treatment Market Drivers
2.3.3 Pulmonary Arterial Hypertension Treatment Market Challenges
2.3.4 Pulmonary Arterial Hypertension Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Pulmonary Arterial Hypertension Treatment Players by Revenue
3.1.1 Global Top Pulmonary Arterial Hypertension Treatment Players by Revenue (2016-2021)
3.1.2 Global Pulmonary Arterial Hypertension Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Pulmonary Arterial Hypertension Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Pulmonary Arterial Hypertension Treatment Revenue
3.4 Global Pulmonary Arterial Hypertension Treatment Market Concentration Ratio
3.4.1 Global Pulmonary Arterial Hypertension Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Pulmonary Arterial Hypertension Treatment Revenue in 2020
3.5 Pulmonary Arterial Hypertension Treatment Key Players Head office and Area Served
3.6 Key Players Pulmonary Arterial Hypertension Treatment Product Solution and Service
3.7 Date of Enter into Pulmonary Arterial Hypertension Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Pulmonary Arterial Hypertension Treatment Breakdown Data by Type
4.1 Global Pulmonary Arterial Hypertension Treatment Historic Market Size by Type (2016-2021)
4.2 Global Pulmonary Arterial Hypertension Treatment Forecasted Market Size by Type (2022-2027)
5 Pulmonary Arterial Hypertension Treatment Breakdown Data by Application
5.1 Global Pulmonary Arterial Hypertension Treatment Historic Market Size by Application (2016-2021)
5.2 Global Pulmonary Arterial Hypertension Treatment Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Pulmonary Arterial Hypertension Treatment Market Size (2016-2027)
6.2 North America Pulmonary Arterial Hypertension Treatment Market Size by Type
6.2.1 North America Pulmonary Arterial Hypertension Treatment Market Size by Type (2016-2021)
6.2.2 North America Pulmonary Arterial Hypertension Treatment Market Size by Type (2022-2027)
6.2.3 North America Pulmonary Arterial Hypertension Treatment Market Size by Type (2016-2027)
6.3 North America Pulmonary Arterial Hypertension Treatment Market Size by Application
6.3.1 North America Pulmonary Arterial Hypertension Treatment Market Size by Application (2016-2021)
6.3.2 North America Pulmonary Arterial Hypertension Treatment Market Size by Application (2022-2027)
6.3.3 North America Pulmonary Arterial Hypertension Treatment Market Size by Application (2016-2027)
6.4 North America Pulmonary Arterial Hypertension Treatment Market Size by Country
6.4.1 North America Pulmonary Arterial Hypertension Treatment Market Size by Country (2016-2021)
6.4.2 North America Pulmonary Arterial Hypertension Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Pulmonary Arterial Hypertension Treatment Market Size (2016-2027)
7.2 Europe Pulmonary Arterial Hypertension Treatment Market Size by Type
7.2.1 Europe Pulmonary Arterial Hypertension Treatment Market Size by Type (2016-2021)
7.2.2 Europe Pulmonary Arterial Hypertension Treatment Market Size by Type (2022-2027)
7.2.3 Europe Pulmonary Arterial Hypertension Treatment Market Size by Type (2016-2027)
7.3 Europe Pulmonary Arterial Hypertension Treatment Market Size by Application
7.3.1 Europe Pulmonary Arterial Hypertension Treatment Market Size by Application (2016-2021)
7.3.2 Europe Pulmonary Arterial Hypertension Treatment Market Size by Application (2022-2027)
7.3.3 Europe Pulmonary Arterial Hypertension Treatment Market Size by Application (2016-2027)
7.4 Europe Pulmonary Arterial Hypertension Treatment Market Size by Country
7.4.1 Europe Pulmonary Arterial Hypertension Treatment Market Size by Country (2016-2021)
7.4.2 Europe Pulmonary Arterial Hypertension Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Pulmonary Arterial Hypertension Treatment Market Size (2016-2027)
8.2 Asia-Pacific Pulmonary Arterial Hypertension Treatment Market Size by Type
8.2.1 Asia-Pacific Pulmonary Arterial Hypertension Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Pulmonary Arterial Hypertension Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Pulmonary Arterial Hypertension Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Pulmonary Arterial Hypertension Treatment Market Size by Application
8.3.1 Asia-Pacific Pulmonary Arterial Hypertension Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Pulmonary Arterial Hypertension Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Pulmonary Arterial Hypertension Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Pulmonary Arterial Hypertension Treatment Market Size by Region
8.4.1 Asia-Pacific Pulmonary Arterial Hypertension Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Pulmonary Arterial Hypertension Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Pulmonary Arterial Hypertension Treatment Market Size (2016-2027)
9.2 Latin America Pulmonary Arterial Hypertension Treatment Market Size by Type
9.2.1 Latin America Pulmonary Arterial Hypertension Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Pulmonary Arterial Hypertension Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Pulmonary Arterial Hypertension Treatment Market Size by Type (2016-2027)
9.3 Latin America Pulmonary Arterial Hypertension Treatment Market Size by Application
9.3.1 Latin America Pulmonary Arterial Hypertension Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Pulmonary Arterial Hypertension Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Pulmonary Arterial Hypertension Treatment Market Size by Application (2016-2027)
9.4 Latin America Pulmonary Arterial Hypertension Treatment Market Size by Country
9.4.1 Latin America Pulmonary Arterial Hypertension Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Pulmonary Arterial Hypertension Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Pulmonary Arterial Hypertension Treatment Market Size (2016-2027)
10.2 Middle East & Africa Pulmonary Arterial Hypertension Treatment Market Size by Type
10.2.1 Middle East & Africa Pulmonary Arterial Hypertension Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Pulmonary Arterial Hypertension Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Pulmonary Arterial Hypertension Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Pulmonary Arterial Hypertension Treatment Market Size by Application
10.3.1 Middle East & Africa Pulmonary Arterial Hypertension Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Pulmonary Arterial Hypertension Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Pulmonary Arterial Hypertension Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Pulmonary Arterial Hypertension Treatment Market Size by Country
10.4.1 Middle East & Africa Pulmonary Arterial Hypertension Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Pulmonary Arterial Hypertension Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 GSK
11.1.1 GSK Company Details
11.1.2 GSK Business Overview
11.1.3 GSK Pulmonary Arterial Hypertension Treatment Introduction
11.1.4 GSK Revenue in Pulmonary Arterial Hypertension Treatment Business (2016-2021)
11.1.5 GSK Recent Development
11.2 Eli Lilly and Company
11.2.1 Eli Lilly and Company Company Details
11.2.2 Eli Lilly and Company Business Overview
11.2.3 Eli Lilly and Company Pulmonary Arterial Hypertension Treatment Introduction
11.2.4 Eli Lilly and Company Revenue in Pulmonary Arterial Hypertension Treatment Business (2016-2021)
11.2.5 Eli Lilly and Company Recent Development
11.3 Pfizer Inc
11.3.1 Pfizer Inc Company Details
11.3.2 Pfizer Inc Business Overview
11.3.3 Pfizer Inc Pulmonary Arterial Hypertension Treatment Introduction
11.3.4 Pfizer Inc Revenue in Pulmonary Arterial Hypertension Treatment Business (2016-2021)
11.3.5 Pfizer Inc Recent Development
11.4 Actelion Inc
11.4.1 Actelion Inc Company Details
11.4.2 Actelion Inc Business Overview
11.4.3 Actelion Inc Pulmonary Arterial Hypertension Treatment Introduction
11.4.4 Actelion Inc Revenue in Pulmonary Arterial Hypertension Treatment Business (2016-2021)
11.4.5 Actelion Inc Recent Development
11.5 United Therapeutic Corporation
11.5.1 United Therapeutic Corporation Company Details
11.5.2 United Therapeutic Corporation Business Overview
11.5.3 United Therapeutic Corporation Pulmonary Arterial Hypertension Treatment Introduction
11.5.4 United Therapeutic Corporation Revenue in Pulmonary Arterial Hypertension Treatment Business (2016-2021)
11.5.5 United Therapeutic Corporation Recent Development
11.6 SteadyMed Ltd
11.6.1 SteadyMed Ltd Company Details
11.6.2 SteadyMed Ltd Business Overview
11.6.3 SteadyMed Ltd Pulmonary Arterial Hypertension Treatment Introduction
11.6.4 SteadyMed Ltd Revenue in Pulmonary Arterial Hypertension Treatment Business (2016-2021)
11.6.5 SteadyMed Ltd Recent Development
11.7 Gilead Sciences, Inc
11.7.1 Gilead Sciences, Inc Company Details
11.7.2 Gilead Sciences, Inc Business Overview
11.7.3 Gilead Sciences, Inc Pulmonary Arterial Hypertension Treatment Introduction
11.7.4 Gilead Sciences, Inc Revenue in Pulmonary Arterial Hypertension Treatment Business (2016-2021)
11.7.5 Gilead Sciences, Inc Recent Development
11.8 Teva Pharmaceuticals Inc
11.8.1 Teva Pharmaceuticals Inc Company Details
11.8.2 Teva Pharmaceuticals Inc Business Overview
11.8.3 Teva Pharmaceuticals Inc Pulmonary Arterial Hypertension Treatment Introduction
11.8.4 Teva Pharmaceuticals Inc Revenue in Pulmonary Arterial Hypertension Treatment Business (2016-2021)
11.8.5 Teva Pharmaceuticals Inc Recent Development
11.9 Bayer AG
11.9.1 Bayer AG Company Details
11.9.2 Bayer AG Business Overview
11.9.3 Bayer AG Pulmonary Arterial Hypertension Treatment Introduction
11.9.4 Bayer AG Revenue in Pulmonary Arterial Hypertension Treatment Business (2016-2021)
11.9.5 Bayer AG Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
    Table 1. Global Pulmonary Arterial Hypertension Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
    Table 2. Key Players of Vasodilators
    Table 3. Key Players of Phosphodiesterase 5 (PDE 5) Inhibitors
    Table 4. Key Players of Endothelin Receptor Antagonists (ERA)
    Table 5. Key Players of Soluble Guanylate Cyclase (SGC) Stimulator
    Table 6. Global Pulmonary Arterial Hypertension Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
    Table 7. Global Pulmonary Arterial Hypertension Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
    Table 8. Global Pulmonary Arterial Hypertension Treatment Market Size by Regions (2016-2021) & (US$ Million)
    Table 9. Global Pulmonary Arterial Hypertension Treatment Market Share by Regions (2016-2021)
    Table 10. Global Pulmonary Arterial Hypertension Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
    Table 11. Global Pulmonary Arterial Hypertension Treatment Market Share by Regions (2022-2027)
    Table 12. Pulmonary Arterial Hypertension Treatment Market Trends
    Table 13. Pulmonary Arterial Hypertension Treatment Market Drivers
    Table 14. Pulmonary Arterial Hypertension Treatment Market Challenges
    Table 15. Pulmonary Arterial Hypertension Treatment Market Restraints
    Table 16. Global Pulmonary Arterial Hypertension Treatment Revenue by Players (2016-2021) & (US$ Million)
    Table 17. Global Pulmonary Arterial Hypertension Treatment Market Share by Players (2016-2021)
    Table 18. Global Top Pulmonary Arterial Hypertension Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pulmonary Arterial Hypertension Treatment as of 2020)
    Table 19. Ranking of Global Top Pulmonary Arterial Hypertension Treatment Companies by Revenue (US$ Million) in 2020
    Table 20. Global 5 Largest Players Market Share by Pulmonary Arterial Hypertension Treatment Revenue (CR5 and HHI) & (2016-2021)
    Table 21. Key Players Headquarters and Area Served
    Table 22. Key Players Pulmonary Arterial Hypertension Treatment Product Solution and Service
    Table 23. Date of Enter into Pulmonary Arterial Hypertension Treatment Market
    Table 24. Mergers & Acquisitions, Expansion Plans
    Table 25. Global Pulmonary Arterial Hypertension Treatment Market Size by Type (2016-2021) (US$ Million)
    Table 26. Global Pulmonary Arterial Hypertension Treatment Revenue Market Share by Type (2016-2021)
    Table 27. Global Pulmonary Arterial Hypertension Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
    Table 28. Global Pulmonary Arterial Hypertension Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
    Table 29. Global Pulmonary Arterial Hypertension Treatment Market Size Share by Application (2016-2021) & (US$ Million)
    Table 30. Global Pulmonary Arterial Hypertension Treatment Revenue Market Share by Application (2016-2021)
    Table 31. Global Pulmonary Arterial Hypertension Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
    Table 32. Global Pulmonary Arterial Hypertension Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
    Table 33. North America Pulmonary Arterial Hypertension Treatment Market Size by Type (2016-2021) (US$ Million)
    Table 34. North America Pulmonary Arterial Hypertension Treatment Market Size by Type (2022-2027) & (US$ Million)
    Table 35. North America Pulmonary Arterial Hypertension Treatment Market Size by Application (2016-2021) (US$ Million)
    Table 36. North America Pulmonary Arterial Hypertension Treatment Market Size by Application (2022-2027) & (US$ Million)
    Table 37. North America Pulmonary Arterial Hypertension Treatment Market Size by Country (2016-2021) & (US$ Million)
    Table 38. North America Pulmonary Arterial Hypertension Treatment Market Size by Country (2022-2027) & (US$ Million)
    Table 39. Europe Pulmonary Arterial Hypertension Treatment Market Size by Type (2016-2021) (US$ Million)
    Table 40. Europe Pulmonary Arterial Hypertension Treatment Market Size by Type (2022-2027) & (US$ Million)
    Table 41. Europe Pulmonary Arterial Hypertension Treatment Market Size by Application (2016-2021) (US$ Million)
    Table 42. Europe Pulmonary Arterial Hypertension Treatment Market Size by Application (2022-2027) & (US$ Million)
    Table 43. Europe Pulmonary Arterial Hypertension Treatment Market Size by Country (2016-2021) & (US$ Million)
    Table 44. Europe Pulmonary Arterial Hypertension Treatment Market Size by Country (2022-2027) & (US$ Million)
    Table 45. Asia-Pacific Pulmonary Arterial Hypertension Treatment Market Size by Type (2016-2021) (US$ Million)
    Table 46. Asia-Pacific Pulmonary Arterial Hypertension Treatment Market Size by Type (2022-2027) & (US$ Million)
    Table 47. Asia-Pacific Pulmonary Arterial Hypertension Treatment Market Size by Application (2016-2021) (US$ Million)
    Table 48. Asia-Pacific Pulmonary Arterial Hypertension Treatment Market Size by Application (2022-2027) & (US$ Million)
    Table 49. Asia-Pacific Pulmonary Arterial Hypertension Treatment Market Size by Region (2016-2021) & (US$ Million)
    Table 50. Asia-Pacific Pulmonary Arterial Hypertension Treatment Market Size by Region (2022-2027) & (US$ Million)
    Table 51. Latin America Pulmonary Arterial Hypertension Treatment Market Size by Type (2016-2021) (US$ Million)
    Table 52. Latin America Pulmonary Arterial Hypertension Treatment Market Size by Type (2022-2027) & (US$ Million)
    Table 53. Latin America Pulmonary Arterial Hypertension Treatment Market Size by Application (2016-2021) (US$ Million)
    Table 54. Latin America Pulmonary Arterial Hypertension Treatment Market Size by Application (2022-2027) & (US$ Million)
    Table 55. Latin America Pulmonary Arterial Hypertension Treatment Market Size by Country (2016-2021) & (US$ Million)
    Table 56. Latin America Pulmonary Arterial Hypertension Treatment Market Size by Country (2022-2027) & (US$ Million)
    Table 57. Middle East & Africa Pulmonary Arterial Hypertension Treatment Market Size by Type (2016-2021) (US$ Million)
    Table 58. Middle East & Africa Pulmonary Arterial Hypertension Treatment Market Size by Type (2022-2027) & (US$ Million)
    Table 59. Middle East & Africa Pulmonary Arterial Hypertension Treatment Market Size by Application (2016-2021) (US$ Million)
    Table 60. Middle East & Africa Pulmonary Arterial Hypertension Treatment Market Size by Application (2022-2027) & (US$ Million)
    Table 61. Middle East & Africa Pulmonary Arterial Hypertension Treatment Market Size by Country (2016-2021) & (US$ Million)
    Table 62. Middle East & Africa Pulmonary Arterial Hypertension Treatment Market Size by Country (2022-2027) & (US$ Million)
    Table 63. GSK Company Details
    Table 64. GSK Business Overview
    Table 65. GSK Pulmonary Arterial Hypertension Treatment Product
    Table 66. GSK Revenue in Pulmonary Arterial Hypertension Treatment Business (2016-2021) & (US$ Million)
    Table 67. GSK Recent Development
    Table 68. Eli Lilly and Company Company Details
    Table 69. Eli Lilly and Company Business Overview
    Table 70. Eli Lilly and Company Pulmonary Arterial Hypertension Treatment Product
    Table 71. Eli Lilly and Company Revenue in Pulmonary Arterial Hypertension Treatment Business (2016-2021) & (US$ Million)
    Table 72. Eli Lilly and Company Recent Development
    Table 73. Pfizer Inc Company Details
    Table 74. Pfizer Inc Business Overview
    Table 75. Pfizer Inc Pulmonary Arterial Hypertension Treatment Product
    Table 76. Pfizer Inc Revenue in Pulmonary Arterial Hypertension Treatment Business (2016-2021) & (US$ Million)
    Table 77. Pfizer Inc Recent Development
    Table 78. Actelion Inc Company Details
    Table 79. Actelion Inc Business Overview
    Table 80. Actelion Inc Pulmonary Arterial Hypertension Treatment Product
    Table 81. Actelion Inc Revenue in Pulmonary Arterial Hypertension Treatment Business (2016-2021) & (US$ Million)
    Table 82. Actelion Inc Recent Development
    Table 83. United Therapeutic Corporation Company Details
    Table 84. United Therapeutic Corporation Business Overview
    Table 85. United Therapeutic Corporation Pulmonary Arterial Hypertension Treatment Product
    Table 86. United Therapeutic Corporation Revenue in Pulmonary Arterial Hypertension Treatment Business (2016-2021) & (US$ Million)
    Table 87. United Therapeutic Corporation Recent Development
    Table 88. SteadyMed Ltd Company Details
    Table 89. SteadyMed Ltd Business Overview
    Table 90. SteadyMed Ltd Pulmonary Arterial Hypertension Treatment Product
    Table 91. SteadyMed Ltd Revenue in Pulmonary Arterial Hypertension Treatment Business (2016-2021) & (US$ Million)
    Table 92. SteadyMed Ltd Recent Development
    Table 93. Gilead Sciences, Inc Company Details
    Table 94. Gilead Sciences, Inc Business Overview
    Table 95. Gilead Sciences, Inc Pulmonary Arterial Hypertension Treatment Product
    Table 96. Gilead Sciences, Inc Revenue in Pulmonary Arterial Hypertension Treatment Business (2016-2021) & (US$ Million)
    Table 97. Gilead Sciences, Inc Recent Development
    Table 98. Teva Pharmaceuticals Inc Company Details
    Table 99. Teva Pharmaceuticals Inc Business Overview
    Table 100. Teva Pharmaceuticals Inc Revenue in Pulmonary Arterial Hypertension Treatment Business (2016-2021) & (US$ Million)
    Table 101. Teva Pharmaceuticals Inc Recent Development
    Table 102. Bayer AG Company Details
    Table 103. Bayer AG Business Overview
    Table 104. Bayer AG Pulmonary Arterial Hypertension Treatment Product
    Table 105. Bayer AG Revenue in Pulmonary Arterial Hypertension Treatment Business (2016-2021) & (US$ Million)
    Table 106. Bayer AG Recent Development
    Table 107. Research Programs/Design for This Report
    Table 108. Key Data Information from Secondary Sources
    Table 109. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Pulmonary Arterial Hypertension Treatment Market Share by Type: 2020 VS 2027
    Figure 2. Vasodilators Features
    Figure 3. Phosphodiesterase 5 (PDE 5) Inhibitors Features
    Figure 4. Endothelin Receptor Antagonists (ERA) Features
    Figure 5. Soluble Guanylate Cyclase (SGC) Stimulator Features
    Figure 6. Global Pulmonary Arterial Hypertension Treatment Market Share by Application: 2020 VS 2027
    Figure 7. Hospital Pharmacies Case Studies
    Figure 8. Retail Pharmacies Case Studies
    Figure 9. Online Pharmacies Case Studies
    Figure 10. Pulmonary Arterial Hypertension Treatment Report Years Considered
    Figure 11. Global Pulmonary Arterial Hypertension Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
    Figure 12. Global Pulmonary Arterial Hypertension Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
    Figure 13. Global Pulmonary Arterial Hypertension Treatment Market Share by Regions: 2020 VS 2027
    Figure 14. Global Pulmonary Arterial Hypertension Treatment Market Share by Regions (2022-2027)
    Figure 15. Global Pulmonary Arterial Hypertension Treatment Market Share by Players in 2020
    Figure 16. Global Top Pulmonary Arterial Hypertension Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pulmonary Arterial Hypertension Treatment as of 2020
    Figure 17. The Top 10 and 5 Players Market Share by Pulmonary Arterial Hypertension Treatment Revenue in 2020
    Figure 18. Global Pulmonary Arterial Hypertension Treatment Revenue Market Share by Type (2016-2021)
    Figure 19. Global Pulmonary Arterial Hypertension Treatment Revenue Market Share by Type (2022-2027)
    Figure 20. North America Pulmonary Arterial Hypertension Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 21. North America Pulmonary Arterial Hypertension Treatment Market Share by Type (2016-2027)
    Figure 22. North America Pulmonary Arterial Hypertension Treatment Market Share by Application (2016-2027)
    Figure 23. North America Pulmonary Arterial Hypertension Treatment Market Share by Country (2016-2027)
    Figure 24. United States Pulmonary Arterial Hypertension Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 25. Canada Pulmonary Arterial Hypertension Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 26. Europe Pulmonary Arterial Hypertension Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 27. Europe Pulmonary Arterial Hypertension Treatment Market Share by Type (2016-2027)
    Figure 28. Europe Pulmonary Arterial Hypertension Treatment Market Share by Application (2016-2027)
    Figure 29. Europe Pulmonary Arterial Hypertension Treatment Market Share by Country (2016-2027)
    Figure 30. Germany Pulmonary Arterial Hypertension Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 31. France Pulmonary Arterial Hypertension Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 32. U.K. Pulmonary Arterial Hypertension Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 33. Italy Pulmonary Arterial Hypertension Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 34. Russia Pulmonary Arterial Hypertension Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 35. Nordic Pulmonary Arterial Hypertension Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 36. Asia-Pacific Pulmonary Arterial Hypertension Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 37. Asia-Pacific Pulmonary Arterial Hypertension Treatment Market Share by Type (2016-2027)
    Figure 38. Asia-Pacific Pulmonary Arterial Hypertension Treatment Market Share by Application (2016-2027)
    Figure 39. Asia-Pacific Pulmonary Arterial Hypertension Treatment Market Share by Region (2016-2027)
    Figure 40. China Pulmonary Arterial Hypertension Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 41. Japan Pulmonary Arterial Hypertension Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 42. South Korea Pulmonary Arterial Hypertension Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 43. Southeast Asia Pulmonary Arterial Hypertension Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 44. India Pulmonary Arterial Hypertension Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 45. Australia Pulmonary Arterial Hypertension Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 46. Latin America Pulmonary Arterial Hypertension Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 47. Latin America Pulmonary Arterial Hypertension Treatment Market Share by Type (2016-2027)
    Figure 48. Latin America Pulmonary Arterial Hypertension Treatment Market Share by Application (2016-2027)
    Figure 49. Latin America Pulmonary Arterial Hypertension Treatment Market Share by Country (2016-2027)
    Figure 50. Mexico Pulmonary Arterial Hypertension Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 51. Brazil Pulmonary Arterial Hypertension Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 52. Middle East & Africa Pulmonary Arterial Hypertension Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 53. Middle East & Africa Pulmonary Arterial Hypertension Treatment Market Share by Type (2016-2027)
    Figure 54. Middle East & Africa Pulmonary Arterial Hypertension Treatment Market Share by Application (2016-2027)
    Figure 55. Middle East & Africa Pulmonary Arterial Hypertension Treatment Market Share by Country (2016-2027)
    Figure 56. Turkey Pulmonary Arterial Hypertension Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 57. Saudi Arabia Pulmonary Arterial Hypertension Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 58. UAE Pulmonary Arterial Hypertension Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 59. GSK Revenue Growth Rate in Pulmonary Arterial Hypertension Treatment Business (2016-2021)
    Figure 60. Eli Lilly and Company Revenue Growth Rate in Pulmonary Arterial Hypertension Treatment Business (2016-2021)
    Figure 61. Pfizer Inc Revenue Growth Rate in Pulmonary Arterial Hypertension Treatment Business (2016-2021)
    Figure 62. Actelion Inc Revenue Growth Rate in Pulmonary Arterial Hypertension Treatment Business (2016-2021)
    Figure 63. United Therapeutic Corporation Revenue Growth Rate in Pulmonary Arterial Hypertension Treatment Business (2016-2021)
    Figure 64. SteadyMed Ltd Revenue Growth Rate in Pulmonary Arterial Hypertension Treatment Business (2016-2021)
    Figure 65. Gilead Sciences, Inc Revenue Growth Rate in Pulmonary Arterial Hypertension Treatment Business (2016-2021)
    Figure 66. Teva Pharmaceuticals Inc Revenue Growth Rate in Pulmonary Arterial Hypertension Treatment Business (2016-2021)
    Figure 67. Bayer AG Revenue Growth Rate in Pulmonary Arterial Hypertension Treatment Business (2016-2021)
    Figure 68. Bottom-up and Top-down Approaches for This Report
    Figure 69. Data Triangulation
    Figure 70. Key Executives Interviewed
Pulmonary Arterial Hypertension Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Pulmonary Arterial Hypertension Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
    Vasodilators
    Phosphodiesterase 5 (PDE 5) Inhibitors
    Endothelin Receptor Antagonists (ERA)
    Soluble Guanylate Cyclase (SGC) Stimulator
Segment by Application
    Hospital Pharmacies
    Retail Pharmacies
    Online Pharmacies
By Region
    North America
        United States
        Canada
    Europe
        Germany
        France
        U.K.
        Italy
        Russia
        Nordic
        Rest of Europe
    Asia-Pacific
        China
        Japan
        South Korea
        Southeast Asia
        India
        Australia
        Rest of Asia
    Latin America
        Mexico
        Brazil
        Rest of Latin America
    Middle East & Africa
        Turkey
        Saudi Arabia
        UAE
        Rest of MEA
By Company
    GSK
    Eli Lilly and Company
    Pfizer Inc
    Actelion Inc
    United Therapeutic Corporation
    SteadyMed Ltd
    Gilead Sciences, Inc
    Teva Pharmaceuticals Inc
    Bayer AG
    Actelion Inc
Read More
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Pulmonary Arterial Hypertension Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Vasodilators
1.2.3 Phosphodiesterase 5 (PDE 5) Inhibitors
1.2.4 Endothelin Receptor Antagonists (ERA)
1.2.5 Soluble Guanylate Cyclase (SGC) Stimulator
1.3 Market by Application
1.3.1 Global Pulmonary Arterial Hypertension Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Pulmonary Arterial Hypertension Treatment Market Perspective (2016-2027)
2.2 Pulmonary Arterial Hypertension Treatment Growth Trends by Regions
2.2.1 Pulmonary Arterial Hypertension Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Pulmonary Arterial Hypertension Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Pulmonary Arterial Hypertension Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Pulmonary Arterial Hypertension Treatment Industry Dynamic
2.3.1 Pulmonary Arterial Hypertension Treatment Market Trends
2.3.2 Pulmonary Arterial Hypertension Treatment Market Drivers
2.3.3 Pulmonary Arterial Hypertension Treatment Market Challenges
2.3.4 Pulmonary Arterial Hypertension Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Pulmonary Arterial Hypertension Treatment Players by Revenue
3.1.1 Global Top Pulmonary Arterial Hypertension Treatment Players by Revenue (2016-2021)
3.1.2 Global Pulmonary Arterial Hypertension Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Pulmonary Arterial Hypertension Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Pulmonary Arterial Hypertension Treatment Revenue
3.4 Global Pulmonary Arterial Hypertension Treatment Market Concentration Ratio
3.4.1 Global Pulmonary Arterial Hypertension Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Pulmonary Arterial Hypertension Treatment Revenue in 2020
3.5 Pulmonary Arterial Hypertension Treatment Key Players Head office and Area Served
3.6 Key Players Pulmonary Arterial Hypertension Treatment Product Solution and Service
3.7 Date of Enter into Pulmonary Arterial Hypertension Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Pulmonary Arterial Hypertension Treatment Breakdown Data by Type
4.1 Global Pulmonary Arterial Hypertension Treatment Historic Market Size by Type (2016-2021)
4.2 Global Pulmonary Arterial Hypertension Treatment Forecasted Market Size by Type (2022-2027)
5 Pulmonary Arterial Hypertension Treatment Breakdown Data by Application
5.1 Global Pulmonary Arterial Hypertension Treatment Historic Market Size by Application (2016-2021)
5.2 Global Pulmonary Arterial Hypertension Treatment Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Pulmonary Arterial Hypertension Treatment Market Size (2016-2027)
6.2 North America Pulmonary Arterial Hypertension Treatment Market Size by Type
6.2.1 North America Pulmonary Arterial Hypertension Treatment Market Size by Type (2016-2021)
6.2.2 North America Pulmonary Arterial Hypertension Treatment Market Size by Type (2022-2027)
6.2.3 North America Pulmonary Arterial Hypertension Treatment Market Size by Type (2016-2027)
6.3 North America Pulmonary Arterial Hypertension Treatment Market Size by Application
6.3.1 North America Pulmonary Arterial Hypertension Treatment Market Size by Application (2016-2021)
6.3.2 North America Pulmonary Arterial Hypertension Treatment Market Size by Application (2022-2027)
6.3.3 North America Pulmonary Arterial Hypertension Treatment Market Size by Application (2016-2027)
6.4 North America Pulmonary Arterial Hypertension Treatment Market Size by Country
6.4.1 North America Pulmonary Arterial Hypertension Treatment Market Size by Country (2016-2021)
6.4.2 North America Pulmonary Arterial Hypertension Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Pulmonary Arterial Hypertension Treatment Market Size (2016-2027)
7.2 Europe Pulmonary Arterial Hypertension Treatment Market Size by Type
7.2.1 Europe Pulmonary Arterial Hypertension Treatment Market Size by Type (2016-2021)
7.2.2 Europe Pulmonary Arterial Hypertension Treatment Market Size by Type (2022-2027)
7.2.3 Europe Pulmonary Arterial Hypertension Treatment Market Size by Type (2016-2027)
7.3 Europe Pulmonary Arterial Hypertension Treatment Market Size by Application
7.3.1 Europe Pulmonary Arterial Hypertension Treatment Market Size by Application (2016-2021)
7.3.2 Europe Pulmonary Arterial Hypertension Treatment Market Size by Application (2022-2027)
7.3.3 Europe Pulmonary Arterial Hypertension Treatment Market Size by Application (2016-2027)
7.4 Europe Pulmonary Arterial Hypertension Treatment Market Size by Country
7.4.1 Europe Pulmonary Arterial Hypertension Treatment Market Size by Country (2016-2021)
7.4.2 Europe Pulmonary Arterial Hypertension Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Pulmonary Arterial Hypertension Treatment Market Size (2016-2027)
8.2 Asia-Pacific Pulmonary Arterial Hypertension Treatment Market Size by Type
8.2.1 Asia-Pacific Pulmonary Arterial Hypertension Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Pulmonary Arterial Hypertension Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Pulmonary Arterial Hypertension Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Pulmonary Arterial Hypertension Treatment Market Size by Application
8.3.1 Asia-Pacific Pulmonary Arterial Hypertension Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Pulmonary Arterial Hypertension Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Pulmonary Arterial Hypertension Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Pulmonary Arterial Hypertension Treatment Market Size by Region
8.4.1 Asia-Pacific Pulmonary Arterial Hypertension Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Pulmonary Arterial Hypertension Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Pulmonary Arterial Hypertension Treatment Market Size (2016-2027)
9.2 Latin America Pulmonary Arterial Hypertension Treatment Market Size by Type
9.2.1 Latin America Pulmonary Arterial Hypertension Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Pulmonary Arterial Hypertension Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Pulmonary Arterial Hypertension Treatment Market Size by Type (2016-2027)
9.3 Latin America Pulmonary Arterial Hypertension Treatment Market Size by Application
9.3.1 Latin America Pulmonary Arterial Hypertension Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Pulmonary Arterial Hypertension Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Pulmonary Arterial Hypertension Treatment Market Size by Application (2016-2027)
9.4 Latin America Pulmonary Arterial Hypertension Treatment Market Size by Country
9.4.1 Latin America Pulmonary Arterial Hypertension Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Pulmonary Arterial Hypertension Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Pulmonary Arterial Hypertension Treatment Market Size (2016-2027)
10.2 Middle East & Africa Pulmonary Arterial Hypertension Treatment Market Size by Type
10.2.1 Middle East & Africa Pulmonary Arterial Hypertension Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Pulmonary Arterial Hypertension Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Pulmonary Arterial Hypertension Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Pulmonary Arterial Hypertension Treatment Market Size by Application
10.3.1 Middle East & Africa Pulmonary Arterial Hypertension Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Pulmonary Arterial Hypertension Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Pulmonary Arterial Hypertension Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Pulmonary Arterial Hypertension Treatment Market Size by Country
10.4.1 Middle East & Africa Pulmonary Arterial Hypertension Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Pulmonary Arterial Hypertension Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 GSK
11.1.1 GSK Company Details
11.1.2 GSK Business Overview
11.1.3 GSK Pulmonary Arterial Hypertension Treatment Introduction
11.1.4 GSK Revenue in Pulmonary Arterial Hypertension Treatment Business (2016-2021)
11.1.5 GSK Recent Development
11.2 Eli Lilly and Company
11.2.1 Eli Lilly and Company Company Details
11.2.2 Eli Lilly and Company Business Overview
11.2.3 Eli Lilly and Company Pulmonary Arterial Hypertension Treatment Introduction
11.2.4 Eli Lilly and Company Revenue in Pulmonary Arterial Hypertension Treatment Business (2016-2021)
11.2.5 Eli Lilly and Company Recent Development
11.3 Pfizer Inc
11.3.1 Pfizer Inc Company Details
11.3.2 Pfizer Inc Business Overview
11.3.3 Pfizer Inc Pulmonary Arterial Hypertension Treatment Introduction
11.3.4 Pfizer Inc Revenue in Pulmonary Arterial Hypertension Treatment Business (2016-2021)
11.3.5 Pfizer Inc Recent Development
11.4 Actelion Inc
11.4.1 Actelion Inc Company Details
11.4.2 Actelion Inc Business Overview
11.4.3 Actelion Inc Pulmonary Arterial Hypertension Treatment Introduction
11.4.4 Actelion Inc Revenue in Pulmonary Arterial Hypertension Treatment Business (2016-2021)
11.4.5 Actelion Inc Recent Development
11.5 United Therapeutic Corporation
11.5.1 United Therapeutic Corporation Company Details
11.5.2 United Therapeutic Corporation Business Overview
11.5.3 United Therapeutic Corporation Pulmonary Arterial Hypertension Treatment Introduction
11.5.4 United Therapeutic Corporation Revenue in Pulmonary Arterial Hypertension Treatment Business (2016-2021)
11.5.5 United Therapeutic Corporation Recent Development
11.6 SteadyMed Ltd
11.6.1 SteadyMed Ltd Company Details
11.6.2 SteadyMed Ltd Business Overview
11.6.3 SteadyMed Ltd Pulmonary Arterial Hypertension Treatment Introduction
11.6.4 SteadyMed Ltd Revenue in Pulmonary Arterial Hypertension Treatment Business (2016-2021)
11.6.5 SteadyMed Ltd Recent Development
11.7 Gilead Sciences, Inc
11.7.1 Gilead Sciences, Inc Company Details
11.7.2 Gilead Sciences, Inc Business Overview
11.7.3 Gilead Sciences, Inc Pulmonary Arterial Hypertension Treatment Introduction
11.7.4 Gilead Sciences, Inc Revenue in Pulmonary Arterial Hypertension Treatment Business (2016-2021)
11.7.5 Gilead Sciences, Inc Recent Development
11.8 Teva Pharmaceuticals Inc
11.8.1 Teva Pharmaceuticals Inc Company Details
11.8.2 Teva Pharmaceuticals Inc Business Overview
11.8.3 Teva Pharmaceuticals Inc Pulmonary Arterial Hypertension Treatment Introduction
11.8.4 Teva Pharmaceuticals Inc Revenue in Pulmonary Arterial Hypertension Treatment Business (2016-2021)
11.8.5 Teva Pharmaceuticals Inc Recent Development
11.9 Bayer AG
11.9.1 Bayer AG Company Details
11.9.2 Bayer AG Business Overview
11.9.3 Bayer AG Pulmonary Arterial Hypertension Treatment Introduction
11.9.4 Bayer AG Revenue in Pulmonary Arterial Hypertension Treatment Business (2016-2021)
11.9.5 Bayer AG Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Read More
List of Tables
    Table 1. Global Pulmonary Arterial Hypertension Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
    Table 2. Key Players of Vasodilators
    Table 3. Key Players of Phosphodiesterase 5 (PDE 5) Inhibitors
    Table 4. Key Players of Endothelin Receptor Antagonists (ERA)
    Table 5. Key Players of Soluble Guanylate Cyclase (SGC) Stimulator
    Table 6. Global Pulmonary Arterial Hypertension Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
    Table 7. Global Pulmonary Arterial Hypertension Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
    Table 8. Global Pulmonary Arterial Hypertension Treatment Market Size by Regions (2016-2021) & (US$ Million)
    Table 9. Global Pulmonary Arterial Hypertension Treatment Market Share by Regions (2016-2021)
    Table 10. Global Pulmonary Arterial Hypertension Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
    Table 11. Global Pulmonary Arterial Hypertension Treatment Market Share by Regions (2022-2027)
    Table 12. Pulmonary Arterial Hypertension Treatment Market Trends
    Table 13. Pulmonary Arterial Hypertension Treatment Market Drivers
    Table 14. Pulmonary Arterial Hypertension Treatment Market Challenges
    Table 15. Pulmonary Arterial Hypertension Treatment Market Restraints
    Table 16. Global Pulmonary Arterial Hypertension Treatment Revenue by Players (2016-2021) & (US$ Million)
    Table 17. Global Pulmonary Arterial Hypertension Treatment Market Share by Players (2016-2021)
    Table 18. Global Top Pulmonary Arterial Hypertension Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pulmonary Arterial Hypertension Treatment as of 2020)
    Table 19. Ranking of Global Top Pulmonary Arterial Hypertension Treatment Companies by Revenue (US$ Million) in 2020
    Table 20. Global 5 Largest Players Market Share by Pulmonary Arterial Hypertension Treatment Revenue (CR5 and HHI) & (2016-2021)
    Table 21. Key Players Headquarters and Area Served
    Table 22. Key Players Pulmonary Arterial Hypertension Treatment Product Solution and Service
    Table 23. Date of Enter into Pulmonary Arterial Hypertension Treatment Market
    Table 24. Mergers & Acquisitions, Expansion Plans
    Table 25. Global Pulmonary Arterial Hypertension Treatment Market Size by Type (2016-2021) (US$ Million)
    Table 26. Global Pulmonary Arterial Hypertension Treatment Revenue Market Share by Type (2016-2021)
    Table 27. Global Pulmonary Arterial Hypertension Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
    Table 28. Global Pulmonary Arterial Hypertension Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
    Table 29. Global Pulmonary Arterial Hypertension Treatment Market Size Share by Application (2016-2021) & (US$ Million)
    Table 30. Global Pulmonary Arterial Hypertension Treatment Revenue Market Share by Application (2016-2021)
    Table 31. Global Pulmonary Arterial Hypertension Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
    Table 32. Global Pulmonary Arterial Hypertension Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
    Table 33. North America Pulmonary Arterial Hypertension Treatment Market Size by Type (2016-2021) (US$ Million)
    Table 34. North America Pulmonary Arterial Hypertension Treatment Market Size by Type (2022-2027) & (US$ Million)
    Table 35. North America Pulmonary Arterial Hypertension Treatment Market Size by Application (2016-2021) (US$ Million)
    Table 36. North America Pulmonary Arterial Hypertension Treatment Market Size by Application (2022-2027) & (US$ Million)
    Table 37. North America Pulmonary Arterial Hypertension Treatment Market Size by Country (2016-2021) & (US$ Million)
    Table 38. North America Pulmonary Arterial Hypertension Treatment Market Size by Country (2022-2027) & (US$ Million)
    Table 39. Europe Pulmonary Arterial Hypertension Treatment Market Size by Type (2016-2021) (US$ Million)
    Table 40. Europe Pulmonary Arterial Hypertension Treatment Market Size by Type (2022-2027) & (US$ Million)
    Table 41. Europe Pulmonary Arterial Hypertension Treatment Market Size by Application (2016-2021) (US$ Million)
    Table 42. Europe Pulmonary Arterial Hypertension Treatment Market Size by Application (2022-2027) & (US$ Million)
    Table 43. Europe Pulmonary Arterial Hypertension Treatment Market Size by Country (2016-2021) & (US$ Million)
    Table 44. Europe Pulmonary Arterial Hypertension Treatment Market Size by Country (2022-2027) & (US$ Million)
    Table 45. Asia-Pacific Pulmonary Arterial Hypertension Treatment Market Size by Type (2016-2021) (US$ Million)
    Table 46. Asia-Pacific Pulmonary Arterial Hypertension Treatment Market Size by Type (2022-2027) & (US$ Million)
    Table 47. Asia-Pacific Pulmonary Arterial Hypertension Treatment Market Size by Application (2016-2021) (US$ Million)
    Table 48. Asia-Pacific Pulmonary Arterial Hypertension Treatment Market Size by Application (2022-2027) & (US$ Million)
    Table 49. Asia-Pacific Pulmonary Arterial Hypertension Treatment Market Size by Region (2016-2021) & (US$ Million)
    Table 50. Asia-Pacific Pulmonary Arterial Hypertension Treatment Market Size by Region (2022-2027) & (US$ Million)
    Table 51. Latin America Pulmonary Arterial Hypertension Treatment Market Size by Type (2016-2021) (US$ Million)
    Table 52. Latin America Pulmonary Arterial Hypertension Treatment Market Size by Type (2022-2027) & (US$ Million)
    Table 53. Latin America Pulmonary Arterial Hypertension Treatment Market Size by Application (2016-2021) (US$ Million)
    Table 54. Latin America Pulmonary Arterial Hypertension Treatment Market Size by Application (2022-2027) & (US$ Million)
    Table 55. Latin America Pulmonary Arterial Hypertension Treatment Market Size by Country (2016-2021) & (US$ Million)
    Table 56. Latin America Pulmonary Arterial Hypertension Treatment Market Size by Country (2022-2027) & (US$ Million)
    Table 57. Middle East & Africa Pulmonary Arterial Hypertension Treatment Market Size by Type (2016-2021) (US$ Million)
    Table 58. Middle East & Africa Pulmonary Arterial Hypertension Treatment Market Size by Type (2022-2027) & (US$ Million)
    Table 59. Middle East & Africa Pulmonary Arterial Hypertension Treatment Market Size by Application (2016-2021) (US$ Million)
    Table 60. Middle East & Africa Pulmonary Arterial Hypertension Treatment Market Size by Application (2022-2027) & (US$ Million)
    Table 61. Middle East & Africa Pulmonary Arterial Hypertension Treatment Market Size by Country (2016-2021) & (US$ Million)
    Table 62. Middle East & Africa Pulmonary Arterial Hypertension Treatment Market Size by Country (2022-2027) & (US$ Million)
    Table 63. GSK Company Details
    Table 64. GSK Business Overview
    Table 65. GSK Pulmonary Arterial Hypertension Treatment Product
    Table 66. GSK Revenue in Pulmonary Arterial Hypertension Treatment Business (2016-2021) & (US$ Million)
    Table 67. GSK Recent Development
    Table 68. Eli Lilly and Company Company Details
    Table 69. Eli Lilly and Company Business Overview
    Table 70. Eli Lilly and Company Pulmonary Arterial Hypertension Treatment Product
    Table 71. Eli Lilly and Company Revenue in Pulmonary Arterial Hypertension Treatment Business (2016-2021) & (US$ Million)
    Table 72. Eli Lilly and Company Recent Development
    Table 73. Pfizer Inc Company Details
    Table 74. Pfizer Inc Business Overview
    Table 75. Pfizer Inc Pulmonary Arterial Hypertension Treatment Product
    Table 76. Pfizer Inc Revenue in Pulmonary Arterial Hypertension Treatment Business (2016-2021) & (US$ Million)
    Table 77. Pfizer Inc Recent Development
    Table 78. Actelion Inc Company Details
    Table 79. Actelion Inc Business Overview
    Table 80. Actelion Inc Pulmonary Arterial Hypertension Treatment Product
    Table 81. Actelion Inc Revenue in Pulmonary Arterial Hypertension Treatment Business (2016-2021) & (US$ Million)
    Table 82. Actelion Inc Recent Development
    Table 83. United Therapeutic Corporation Company Details
    Table 84. United Therapeutic Corporation Business Overview
    Table 85. United Therapeutic Corporation Pulmonary Arterial Hypertension Treatment Product
    Table 86. United Therapeutic Corporation Revenue in Pulmonary Arterial Hypertension Treatment Business (2016-2021) & (US$ Million)
    Table 87. United Therapeutic Corporation Recent Development
    Table 88. SteadyMed Ltd Company Details
    Table 89. SteadyMed Ltd Business Overview
    Table 90. SteadyMed Ltd Pulmonary Arterial Hypertension Treatment Product
    Table 91. SteadyMed Ltd Revenue in Pulmonary Arterial Hypertension Treatment Business (2016-2021) & (US$ Million)
    Table 92. SteadyMed Ltd Recent Development
    Table 93. Gilead Sciences, Inc Company Details
    Table 94. Gilead Sciences, Inc Business Overview
    Table 95. Gilead Sciences, Inc Pulmonary Arterial Hypertension Treatment Product
    Table 96. Gilead Sciences, Inc Revenue in Pulmonary Arterial Hypertension Treatment Business (2016-2021) & (US$ Million)
    Table 97. Gilead Sciences, Inc Recent Development
    Table 98. Teva Pharmaceuticals Inc Company Details
    Table 99. Teva Pharmaceuticals Inc Business Overview
    Table 100. Teva Pharmaceuticals Inc Revenue in Pulmonary Arterial Hypertension Treatment Business (2016-2021) & (US$ Million)
    Table 101. Teva Pharmaceuticals Inc Recent Development
    Table 102. Bayer AG Company Details
    Table 103. Bayer AG Business Overview
    Table 104. Bayer AG Pulmonary Arterial Hypertension Treatment Product
    Table 105. Bayer AG Revenue in Pulmonary Arterial Hypertension Treatment Business (2016-2021) & (US$ Million)
    Table 106. Bayer AG Recent Development
    Table 107. Research Programs/Design for This Report
    Table 108. Key Data Information from Secondary Sources
    Table 109. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Pulmonary Arterial Hypertension Treatment Market Share by Type: 2020 VS 2027
    Figure 2. Vasodilators Features
    Figure 3. Phosphodiesterase 5 (PDE 5) Inhibitors Features
    Figure 4. Endothelin Receptor Antagonists (ERA) Features
    Figure 5. Soluble Guanylate Cyclase (SGC) Stimulator Features
    Figure 6. Global Pulmonary Arterial Hypertension Treatment Market Share by Application: 2020 VS 2027
    Figure 7. Hospital Pharmacies Case Studies
    Figure 8. Retail Pharmacies Case Studies
    Figure 9. Online Pharmacies Case Studies
    Figure 10. Pulmonary Arterial Hypertension Treatment Report Years Considered
    Figure 11. Global Pulmonary Arterial Hypertension Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
    Figure 12. Global Pulmonary Arterial Hypertension Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
    Figure 13. Global Pulmonary Arterial Hypertension Treatment Market Share by Regions: 2020 VS 2027
    Figure 14. Global Pulmonary Arterial Hypertension Treatment Market Share by Regions (2022-2027)
    Figure 15. Global Pulmonary Arterial Hypertension Treatment Market Share by Players in 2020
    Figure 16. Global Top Pulmonary Arterial Hypertension Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pulmonary Arterial Hypertension Treatment as of 2020
    Figure 17. The Top 10 and 5 Players Market Share by Pulmonary Arterial Hypertension Treatment Revenue in 2020
    Figure 18. Global Pulmonary Arterial Hypertension Treatment Revenue Market Share by Type (2016-2021)
    Figure 19. Global Pulmonary Arterial Hypertension Treatment Revenue Market Share by Type (2022-2027)
    Figure 20. North America Pulmonary Arterial Hypertension Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 21. North America Pulmonary Arterial Hypertension Treatment Market Share by Type (2016-2027)
    Figure 22. North America Pulmonary Arterial Hypertension Treatment Market Share by Application (2016-2027)
    Figure 23. North America Pulmonary Arterial Hypertension Treatment Market Share by Country (2016-2027)
    Figure 24. United States Pulmonary Arterial Hypertension Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 25. Canada Pulmonary Arterial Hypertension Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 26. Europe Pulmonary Arterial Hypertension Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 27. Europe Pulmonary Arterial Hypertension Treatment Market Share by Type (2016-2027)
    Figure 28. Europe Pulmonary Arterial Hypertension Treatment Market Share by Application (2016-2027)
    Figure 29. Europe Pulmonary Arterial Hypertension Treatment Market Share by Country (2016-2027)
    Figure 30. Germany Pulmonary Arterial Hypertension Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 31. France Pulmonary Arterial Hypertension Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 32. U.K. Pulmonary Arterial Hypertension Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 33. Italy Pulmonary Arterial Hypertension Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 34. Russia Pulmonary Arterial Hypertension Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 35. Nordic Pulmonary Arterial Hypertension Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 36. Asia-Pacific Pulmonary Arterial Hypertension Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 37. Asia-Pacific Pulmonary Arterial Hypertension Treatment Market Share by Type (2016-2027)
    Figure 38. Asia-Pacific Pulmonary Arterial Hypertension Treatment Market Share by Application (2016-2027)
    Figure 39. Asia-Pacific Pulmonary Arterial Hypertension Treatment Market Share by Region (2016-2027)
    Figure 40. China Pulmonary Arterial Hypertension Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 41. Japan Pulmonary Arterial Hypertension Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 42. South Korea Pulmonary Arterial Hypertension Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 43. Southeast Asia Pulmonary Arterial Hypertension Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 44. India Pulmonary Arterial Hypertension Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 45. Australia Pulmonary Arterial Hypertension Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 46. Latin America Pulmonary Arterial Hypertension Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 47. Latin America Pulmonary Arterial Hypertension Treatment Market Share by Type (2016-2027)
    Figure 48. Latin America Pulmonary Arterial Hypertension Treatment Market Share by Application (2016-2027)
    Figure 49. Latin America Pulmonary Arterial Hypertension Treatment Market Share by Country (2016-2027)
    Figure 50. Mexico Pulmonary Arterial Hypertension Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 51. Brazil Pulmonary Arterial Hypertension Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 52. Middle East & Africa Pulmonary Arterial Hypertension Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 53. Middle East & Africa Pulmonary Arterial Hypertension Treatment Market Share by Type (2016-2027)
    Figure 54. Middle East & Africa Pulmonary Arterial Hypertension Treatment Market Share by Application (2016-2027)
    Figure 55. Middle East & Africa Pulmonary Arterial Hypertension Treatment Market Share by Country (2016-2027)
    Figure 56. Turkey Pulmonary Arterial Hypertension Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 57. Saudi Arabia Pulmonary Arterial Hypertension Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 58. UAE Pulmonary Arterial Hypertension Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 59. GSK Revenue Growth Rate in Pulmonary Arterial Hypertension Treatment Business (2016-2021)
    Figure 60. Eli Lilly and Company Revenue Growth Rate in Pulmonary Arterial Hypertension Treatment Business (2016-2021)
    Figure 61. Pfizer Inc Revenue Growth Rate in Pulmonary Arterial Hypertension Treatment Business (2016-2021)
    Figure 62. Actelion Inc Revenue Growth Rate in Pulmonary Arterial Hypertension Treatment Business (2016-2021)
    Figure 63. United Therapeutic Corporation Revenue Growth Rate in Pulmonary Arterial Hypertension Treatment Business (2016-2021)
    Figure 64. SteadyMed Ltd Revenue Growth Rate in Pulmonary Arterial Hypertension Treatment Business (2016-2021)
    Figure 65. Gilead Sciences, Inc Revenue Growth Rate in Pulmonary Arterial Hypertension Treatment Business (2016-2021)
    Figure 66. Teva Pharmaceuticals Inc Revenue Growth Rate in Pulmonary Arterial Hypertension Treatment Business (2016-2021)
    Figure 67. Bayer AG Revenue Growth Rate in Pulmonary Arterial Hypertension Treatment Business (2016-2021)
    Figure 68. Bottom-up and Top-down Approaches for This Report
    Figure 69. Data Triangulation
    Figure 70. Key Executives Interviewed
Read More
SELECT A FORMAT
Added to Cart

Single User

Electronic (PDF)
$3900
This license allows only one user(purchaser of the report) to access the PDF.

Multi User

Electronic (PDF)
$5850
This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)
$7800
This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (10% Discount)
OUR CUSTOMER
Strategic Venue Partners

RELATED REPORTS

Global Interventional Cardiology Market Research Report 2021
Global Interventional Cardiology Market Research Report 2021

120 Pages
Type: Report
Code: QYRE-Auto-19V4307
Thu Feb 04 00:00:00 UTC 2021

Add to Cart

Global Cardiac Pacing Market Research Report 2021
Global Cardiac Pacing Market Research Report 2021

120 Pages
Type: Report
Code: QYRE-Auto-30L4120
Thu Feb 04 00:00:00 UTC 2021

Add to Cart

Global Peripheral Vascular Devices Market Research Report 2021
Global Peripheral Vascular Devices Market Research Report 2021

120 Pages
Type: Report
Code: QYRE-Auto-14V4329
Thu Feb 04 00:00:00 UTC 2021

Add to Cart

Global Venous Stents Market Research Report 2021
Global Venous Stents Market Research Report 2021

120 Pages
Type: Report
Code: QYRE-Auto-15Q4327
Mon Feb 01 00:00:00 UTC 2021

Add to Cart

0 Items
X
No items in the cart.
$0.0